COVID-19急性后遗症患者的认知障碍与脑代谢改变:一项[18F]FDG PET/CT队列研究的启示
在PERSICOR前瞻性研究中,87例伴神经认知症状的COVID-19急性后遗症(PASC)成人接受脑[18F]FDG PET/CT,与疫情前招募的55例健康对照比较。患者常见注意力困难(79%)和即刻/工作记忆受损(66%),左侧梭状回、杏仁核、海马旁区及蚓部存在显著低代谢,脑桥代谢下降最明显(全组较对照下降5.5%)。注意力与记忆障碍分别与前额叶及内侧/下颞叶代谢减低相关(均P<0.01)。
要点
- PASC伴神经认知症状患者常见注意力困难(79%)和即刻/工作记忆受损(66%)。
- 左侧梭状回(33%)、杏仁核(左23%、右28%)、海马旁区(左25%、右24%)及蚓部(22%)见显著低代谢。
- 脑桥全组较对照下降5.5%,右侧杏仁核下降4.2%;注意力与记忆障碍分别与前额叶、内侧/下颞叶代谢减低相关(均P<0.01)。
核心结论
- 本研究强调PASC中神经症状与特定脑区低代谢之间的联系,并揭示PASC复杂的神经病理生理机制,为潜在治疗干预铺路。
研究设计与样本
- PERSICOR前瞻性研究纳入87例伴神经认知症状的PASC成人,行脑[18F]FDG PET/CT,并与疫情前招募的55例健康对照比较。
- PET图像采用SPM12软件进行体素水平比较(P<0.05,错误发现率校正),并以BrainVisa软件进行感兴趣区分析。
- 研究评估急性COVID-19后时间间隔与脑代谢差异,并分析脑代谢与神经认知症状的相关性。
主要发现
- 常见神经症状包括注意力困难(79%)和即刻/工作记忆受损(66%)。
- 显著低代谢见于左侧梭状回(33%患者)、杏仁核(左23%、右28%)、海马旁区(左25%、右24%)及蚓部(22%)。
- 全组患者脑桥代谢较对照下降5.5%,右侧杏仁核下降4.2%。
- 注意力与记忆障碍分别与前额叶及内侧/下颞叶代谢减低相关(均P<0.01)。
- PET与急性期间隔较短与脑干、丘脑、内侧颞叶、额底皮质及嗅球葡萄糖代谢减低相关(P<10^-3)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Neurological symptoms often prominent in post-acute sequelae of COVID-19 (PASC) necessitate deeper understanding. Our objective was to investigate brain metabolism in PASC and examine correlations with neurological symptoms during both the acute and chronic stages. METHODS: Eighty-seven adults experiencing PASC with neurocognitive symptoms were recruited in the PERSICOR prospective study and examined using brain [ 18 F]FDG PET/CT. Comprehensive clinical variables including neurocognitive symptoms were evaluated. PET images were compared voxel-wise with SPM12 software ( P < 0.05, false discovery rate corrected) and volume-of-interest basis (BrainVisa software) with those of 55 healthy controls recruited before COVID-19 pandemic. We also investigated differences in brain metabolism according to the time interval after acute COVID-19. The correlation between brain metabolism and neurocognitive symptoms was assessed. RESULTS: Frequently reported neurological symptoms included concentration difficulties (79%) and immediate/working memory impairments (66%). Significant hypometabolism was identified in regions previously identified in PASC: left fusiform gyrus (33% of patients), amygdala (23% on left, 28% on right), parahippocampal area (25% left, 24% right), and vermis (22%). The most substantial metabolism decreases were observed in the pons (5.5% decrease in the whole patient group vs controls) and right amygdala (-4.2%). Concentration and memory impairments correlated with decreased metabolism in prefrontal and mesial/inferior temporal areas, respectively ( P < 0.01 for both). A shorter interval between PET imaging and the acute phase of COVID-19 correlated with reduced glucose metabolism in the brainstem, thalamus, mesiotemporal lobe, frontobasal cortex, and olfactory bulb ( P < 10 -3 ). CONCLUSIONS: This study underscores the links between neurological symptoms and cerebral hypometabolism in specific regions in PASC. These findings illuminate the complex neuropathophysiological mechanisms of PASC and pave the way for potential therapeutic interventions.
引用
- Rozenblum L, Debroucker T, Habert MO, et al. Cognitive Impairment and Brain Metabolic Changes in Post-Acute Sequelae of COVID-19: Insights From an [ 18 F]FDG PET/CT Cohort Study. Clin Nucl Med. 2024. PMID: 39690505. doi:10.1097/RLU.0000000000005614
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。